Impact of the response to platinum-based chemotherapy on the second-line immune checkpoint inhibitor monotherapy in non-small cell lung cancer with PD-L1 expression ≤49%: a multicenter retrospective…

Overview of attention for article published in Frontiers in oncology, January 2024

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 1 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 24,137 followers.

RT @FrontOncology: New research: Impact of the response to platinum-based chemotherapy on the second-line immune checkpoint inhibitor monot…

27 Jan 2024

Reply Repost Favourite

RT @FrontOncology: New research: Impact of the response to platinum-based chemotherapy on the second-line immune checkpoint inhibitor monot…

27 Jan 2024

Reply Repost Favourite

New research: Impact of the response to platinum-based chemotherapy on the second-line immune checkpoint inhibitor monotherapy in non-small cell lung cancer with PD-L1 expression ≤49%: a multicenter retrospective study: Introduction The… https://t.co/BZ0M

27 Jan 2024

Reply Repost Favourite

Impact of the response to platinum-based chemotherapy on the second-line immune checkpoint inhibitor monotherapy in non-small cell lung cancer with PD-L1 expression ≤49%: a multicenter retrospective study https://t.co/tQlizHRzTT

26 Jan 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.